This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.70% per year. These returns cover a period from January 1, 1988 through April 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
medical-devices: Archive
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
by Zacks Equity Research
Cardinal Health's specialty growth, strong cash flow and expanding higher-margin businesses are boosting earnings momentum despite IRA and GMPD risks.
CAHNegative Net Change GMEDNegative Net Change PACBPositive Net Change BDSXPositive Net Change
medical medical-devices
PACB & Blank Bio Partner to Advance RNA Foundation Models in Oncology
by Zacks Equity Research
PacBio teams with Blank Bio after its $7.2M seed round, using HiFi long reads to build RNA AI models from patient tumor samples.
ISRGPositive Net Change WSTPositive Net Change GMEDNegative Net Change PACBPositive Net Change
medical medical-devices
Top China Tech Plays in US Markets Amid Trade Deal Progress
by Vasundhara Sawalka
Kingsoft Cloud and peers gain appeal as U.S.-China trade easing and policy shifts lift confidence in Chinese tech into 2026.
TCEHYNegative Net Change TSMNegative Net Change PDDPositive Net Change KCNegative Net Change
artificial-intelligence china electric-vehicles medical-devices semiconductor
Veeva Systems' RTSM Momentum Signals Another Long-Term Growth Driver
by Harshit Gupta
VEEV benefits from RTSM traction with major pharma wins, strengthening its clinical software strategy and long-term R&D growth outlook.
CRMPositive Net Change VEEVPositive Net Change IQVPositive Net Change
medical medical-devices
OPRX Boosts DSP Revenue Potential While Navigating Near-Term Headwinds
by Shreya Majumder
OptimizeRx expands DSP integration to unlock scalable EHR ad campaigns and boost inventory use despite lowering 2026 revenue guidance.
OPRXPositive Net Change VEEVPositive Net Change DOCSPositive Net Change
ad-tech business-services medical medical-devices robotics tech-stocks
Is This the Right Time to Retain ILMN Stock in Your Portfolio?
by Zacks Equity Research
Illumina advances its sequencing strategy with strong NovaSeq X momentum and clinical demand, but China's weakness and macro pressures cloud the outlook.
ALGNPositive Net Change ILMNPositive Net Change GMEDNegative Net Change PAHCNegative Net Change
medical medical-devices
Abbott's Biosimilar Push to Help Sustain EPD Growth Momentum
by Moumi Mondal
ABT's EPD unit posts 9% Q1 sales growth as biosimilars and emerging market demand support its long-term expansion plans.
ABTNegative Net Change BSXNegative Net Change QGENNegative Net Change
medical medical-devices
Globus Medical and Conagra Brands have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
GMED jumps as Globus Medical boosts EPS guidance after a Q1 earnings beat, while Conagra faces margin pressure and estimate cuts.
NKENegative Net Change CAGNegative Net Change LULUNegative Net Change ADDYYNegative Net Change GMEDNegative Net Change
consumer-discretionary consumer-staples medical-devices
Silver Economy Investing: Why the Healthcare Giants Are in Focus
by Urmimala Biswas
Healthcare giants like Eli Lilly, Tandem Diabetes, Intuitive Surgical and ResMed are tapping aging-driven demand in obesity, surgery and sleep care.
ABTNegative Net Change LLYNegative Net Change MDTNegative Net Change ISRGPositive Net Change RMDNegative Net Change TNDMPositive Net Change
biotechs cell-therapy healthcare medical medical-devices pharmaceuticals
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
by Indrajit Bandyopadhyay
Cardinal Health is expanding beyond drug distribution into specialty care, logistics and nuclear medicine, deepening its role in US healthcare infrastructure.
CAHNegative Net Change HIMSPositive Net Change LFMDNegative Net Change
medical medical-devices